Apollo Hospitals and Dr Reddy's Laboratories on Monday said they are collaborating to initiate a COVID-19 vaccination programme in the country with Sputnik V. IMAGE: Second batch of Sputnik-V......
India is expecting 156 million doses of the vaccine from August to September, reports Ruchika Chitravanshi. Photograph: Kind courtesy Russian Direct Investment Fund on Facebook Sputnik V, the......
This could also be India's first vaccine for children aged 12 years and above as the company has conducted trials on the age group. The decision, however, lies with the regulator, reports Sohini......
‘No approval was given to Sputnik V on Thursday. Some queries have been asked on safety, efficacy, and logistics, which the firm will have answers to at the next meeting’ IMAGE:......
‘We expect to get the approval in the next few weeks,’ says Deepak Sapra, CEO, API and pharmaceutical services, Dr Reddy’s Laboratories (DRL). IMAGE: Medics administer the first......
Dr Reddy’s Laboratories (DRL) is set to acquire Haleon’s global portfolio of consumer healthcare brands in the nicotine replacement therapy (NRT) category outside of the US.......
Rajesh Karkera/Rediff.com takes the latest offering from the Mahindra stable for a spin. Photographs and video: Hitesh Harisinghani/Rediff.com One more XUV (Crossover Utility Vehicle) from......
In recent months, several pharma multinational corporations (MNCs) are increasingly turning to Indian companies to expand market reach in the country’s pharmaceuticals sector. Illustration:......
Rising penetration of trade generic medicines is eating into the value growth of the domestic pharmaceutical market, showed a recent analysis. Photograph: Jacky Naegelen/Reuters According to a......
India’s third-largest pharmaceutical company by revenue, Cipla, is up for grabs in a three-way fight between Torrent Pharmaceuticals, Dr Reddy’s Laboratories (DRL) and private equity......